BioCentury
ARTICLE | Company News

Santaris, Roche deal

September 8, 2014 7:00 AM UTC

Roche completed its acquisition of partner Santaris for $250 million in cash up front and up to $200 million in undisclosed milestones. In January, Santaris and Roche partnered to discover and develop...